Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01752478
Other study ID # UCSF-Retina
Secondary ID
Status Completed
Phase N/A
First received December 14, 2012
Last updated May 18, 2016
Start date January 2013
Est. completion date May 2016

Study information

Verified date May 2016
Source University of California, San Francisco
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational [Patient Registry]

Clinical Trial Summary

The purpose of this study to is to determine the incidence of post-operative ptosis in patients undergoing vitreoretinal surgery. An additional purpose is to identify pre-operative and intra-operative factors which correlate to the development of post-operative ptosis in vitreoretinal surgery cases.


Description:

This study will evaluate patients who will undergo vitreoretinal surgery at UCSF Medical Center and San Francisco General Hospital. After informed consent has been obtained, the measurement of eyelid parameters such as levator function, palpebral fissure height, upper eyelid crease height, MRD1 and MRD2 will be collected at pre-operative and post-operative follow up visits. External eye photographs taken at each visit will be evaluated by a masked reader who will calculate the eyelid parameters. Dermographic data and intraoperative factors such as operative time and type of procedure will be collected. For statistical analysis, Repeated ANOVA, Paired t-test, Wilcoxon signed rank test, Chi-square test and Pearson's correlation analysis will be calculated with SPSS software.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date May 2016
Est. primary completion date May 2016
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patients who have vitreoretinal surgery from January 2013

Exclusion Criteria:

- Minors, younger than age 18.

- Patients who have pre-existing ptosis at baseline in the operative eye.

- Patients who are not able to cooperate with eyelid ptosis measurements

Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms

  • Development of Ptosis After Vitreo-retinal Surgery
  • Prolapse

Locations

Country Name City State
United States University of California, San Francisco San Francisco California

Sponsors (1)

Lead Sponsor Collaborator
University of California, San Francisco

Country where clinical trial is conducted

United States, 

References & Publications (7)

Bernardino CR, Rubin PA. Ptosis after cataract surgery. Semin Ophthalmol. 2002 Sep-Dec;17(3-4):144-8. Review. — View Citation

Donker DL, Paridaens D, Mooy CM, van den Bosch WA. Blepharoptosis and upper eyelid swelling due to lipogranulomatous inflammation caused by silicone oil. Am J Ophthalmol. 2005 Nov;140(5):934-6. — View Citation

Edmonson BC, Wulc AE. Ptosis evaluation and management. Otolaryngol Clin North Am. 2005 Oct;38(5):921-46. Review. — View Citation

Kasbekar SA, Wong V, Young J, Stappler T, Durnian JM. Strabismus following retinal detachment repair: a comparison between scleral buckling and vitrectomy procedures. Eye (Lond). 2011 Sep;25(9):1202-6. doi: 10.1038/eye.2011.152. Epub 2011 Jun 24. — View Citation

Paris GL, Quickert MH. Disinsertion of the aponeurosis of the levator palpebrae superioris muscle after cataract extraction. Am J Ophthalmol. 1976 Mar;81(3):337-40. — View Citation

Quintyn JC, Genevois O, Ranty ML, Retout A. Silicone oil migration in the eyelid after vitrectomy for retinal detachment. Am J Ophthalmol. 2003 Sep;136(3):540-2. — View Citation

Ropo A, Ruusuvaara P, Nikki P. Ptosis following periocular or general anaesthesia in cataract surgery. Acta Ophthalmol (Copenh). 1992 Apr;70(2):262-5. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Reduction of levator function Difference between levator function at baseline and 6 months after surgery Baseline to 6 months No
Secondary Operative time Record of operative surgical time in each type of operation At operation No
Secondary Change of palpebral fissure height, MRD1 and MRD2 Difference in palpebral fissure height, MRD1 and MRD2 between baseline and each post-operative visit. Baseline to 6 months No
Secondary Incidence of ptosis Incidence of clinically significant ptosis, defined as upper eyelid drooping of more than 2 mm. baseline to 6 months No